Leal Bridges the Gap between

Cancer Patients & Biopharma

image

Results Received by leal Customers

40% more

qualified patient leads

70% of patients

convert from

ICF

to Randomization

35% of patients

represent ethnic minorities

Reduce time

spent on prequalification by

up to 25%

5x more patients

10 to 15% of Leal’s patients enroll versus the 2 to 3% industry enrollment rate

12% improvement

in minority patient representation across clinical trials

20% reduction

in enrollment timelines. Saving $2.7M in out of pocket costs and $46M to $597M overall

Increased enrollment

through real-time patient feedback on clinical trial enrollment barriers

leal Delivers:

image

Highly Pre Qualified Patients

image

Marketing Efficiency

image

Real World Representation

image

Increased Marketing ROI

image

Reduced Pre Screening

image

Focus Groups & Surveys

image

Patient Journey Analysis

image

Real time patient feedback

quote up symbol

“All of our enrollments have been sourced by leal”

author-default-pic

Sr. Dir. Clinical Research Partnerships at the world’s largest diagnostics company regarding 3 MF trials.

our-mission-photo

Our mission

Leal is an artificial intelligence (AI)-powered patient-centric decision-support platform bridging the gap between patients and pharma, biotech, and CROs for clinical trials. Leal’s unique model empowers cancer patients to own their treatment journey by creating a personalized treatment plan that enhances physician point of care. The Patient Match Optimizer Software as a Service (SaaS) platform delivers actionable insights that directly influence trial design, improve operational processes, and marketing communication strategies, while ensuring alignment with patients' needs and expectations.

Leal leverages AI and deep expertise to expedite clinical recruitment while leveraging first hand patient feedback to continuously improve.

image
icon
11,002

treatments

icon
3,125,000

Treatment Matches

Patient Match Optimizer: Access to a dynamic dashboard providing de-identified and aggregate datasets in real-time.

  • Identify patient barriers and motivators (i.e. treatment side effects, site locations, number of site visits, study phase, how the drug is being administered, etc.)

  • Identify patient-match locations in relation to your active sites, including travel preferences

  • Competitive landscape and insights

  • Suggested study sites within the travel preferences of pre-identified eligible patients

  • Program / Indication-level data, insights and trends

image
image

Latest Publications and articles

articles logo

Business Insider

These are the 16 most promising healthcare startups of 2023, according to top VCs

Learn morearrow
articles logo

FierceBiotech

Leal Health adds a 'first' with FDA-approved cancer treatment decision support service

Learn morearrow
articles logo

The Cancer Letter

Leal Health establishes proprietary platform for oncologists to obtain personalized clinical trial matches for patients

Learn morearrow
Show all

THE BEST INVENTIONS OF 2020

time magazine logo

World changing ideas 2021

world changing idea logo

Our partners

image
image
image
image
image
image
image
image
image
image
image
image
image
image
image
image
image
image
image
image
image
image
image
image